Business Description
Biomind Labs Inc
NAICS : 541710
SIC : 3741
ISIN : CA0907021012
Total Employee Number:
3Description
Biomind Labs Inc is a biotech research and development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. The firm is developing pharmaceutical solutions and combined formulations of the main natural psychedelic molecules with the objective of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -130.9 | |||||
Debt-to-Equity | -0.43 | |||||
Debt-to-EBITDA | -0.96 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 35.8 | |||||
3-Year EPS without NRI Growth Rate | 34.3 | |||||
3-Year FCF Growth Rate | 70.5 | |||||
3-Year Book Growth Rate | -83.7 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
14-Day RSI | 30.37 | |||||
6-1 Month Momentum % | -40.65 | |||||
12-1 Month Momentum % | -85.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Quick Ratio | 0.01 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.2 | |||||
Shareholder Yield % | 2.65 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -3096.2 | |||||
ROIC % | -86.77 | |||||
3-Year ROIIC % | 221.97 | |||||
ROC (Joel Greenblatt) % | -4028.57 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -4.41 | |||||
EV-to-EBITDA | -4.41 | |||||
EV-to-FCF | -33.01 | |||||
Earnings Yield (Greenblatt) % | -22.68 | |||||
FCF Yield % | -4.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biomind Labs Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.01 | ||
| Beta | 3.8444 | ||
| 3-Year Sharpe Ratio | 0.78 | ||
| 3-Year Sortino Ratio | 15.59 | ||
| Volatility % | 82.31 | ||
| 14-Day RSI | 30.37 | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 0.0365 | ||
| 12-1 Month Momentum % | -85.16 | ||
| 52-Week Range (€) | 0.0365 - 0.246 | ||
| Shares Outstanding (Mil) | 77.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biomind Labs Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biomind Labs Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biomind Labs Inc Frequently Asked Questions
What is Biomind Labs Inc(FRA:3XI)'s stock price today?
The current price of FRA:3XI is €0.04. The 52 week high of FRA:3XI is €0.25 and 52 week low is €0.04.
When is next earnings date of Biomind Labs Inc(FRA:3XI)?
The next earnings date of Biomind Labs Inc(FRA:3XI) is .
Does Biomind Labs Inc(FRA:3XI) pay dividends? If so, how much?
Biomind Labs Inc(FRA:3XI) does not pay dividend.
Press Release
Articles on Biomind Labs Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers